Literature DB >> 21037087

Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow.

Judith M E M Cosemans1, Saskia E M Schols, Lucia Stefanini, Susanne de Witt, Marion A H Feijge, Karly Hamulyák, Hans Deckmyn, Wolfgang Bergmeier, Johan W M Heemskerk.   

Abstract

A microscopic method was developed to study the role of platelets in fibrin formation. Perfusion of adhered platelets with plasma under coagulating conditions at a low shear rate (250(-1)) resulted in the assembly of a star-like fibrin network at the platelet surface. The focal fibrin formation on platelets was preceded by rises in cytosolic Ca(2+), morphologic changes, and phosphatidylserine exposure. Fibrin formation was slightly affected by α(IIb)β(3) blockage, but it was greatly delayed and reduced by the following: inhibition of thrombin or platelet activation; interference in the binding of von Willebrand factor (VWF) to glycoprotein Ib/V/IX (GpIb-V-IX); plasma or blood from patients with type 1 von Willebrand disease; and plasma from mice deficient in VWF or the extracellular domain of GpIbα. In this process, the GpIb-binding A1 domain of VWF was similarly effective as full-length VWF. Prestimulation of platelets enhanced the formation of fibrin, which was abrogated by blockage of phosphatidylserine. Together, these results show that, in the presence of thrombin and low shear flow, VWF-induced activation of GpIb-V-IX triggers platelet procoagulant activity and anchorage of a star-like fibrin network. This process can be relevant in hemostasis and the manifestation of von Willebrand disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037087      PMCID: PMC3320850          DOI: 10.1182/blood-2010-01-262683

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

Review 1.  Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice.

Authors:  Wolfgang Bergmeier; Anil K Chauhan; Denisa D Wagner
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

Review 2.  Platelet response heterogeneity in thrombus formation.

Authors:  Imke C A Munnix; Judith M E M Cosemans; Jocelyn M Auger; Johan W M Heemskerk
Journal:  Thromb Haemost       Date:  2009-12       Impact factor: 5.249

3.  Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor.

Authors:  Y Takahashi; M Kalafatis; J P Girma; K Sewerin; L O Andersson; D Meyer
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

4.  Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.

Authors:  H J Weiss; I I Sussman; L W Hoyer
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  CalDAG-GEFI is at the nexus of calcium-dependent platelet activation.

Authors:  Lucia Stefanini; R Claire Roden; Wolfgang Bergmeier
Journal:  Blood       Date:  2009-07-23       Impact factor: 22.113

6.  The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface.

Authors:  Cees Weeterings; Philip G de Groot; Jelle Adelmeijer; Ton Lisman
Journal:  Blood       Date:  2008-07-08       Impact factor: 22.113

7.  Fibrin monomer induces binding of endogenous platelet von Willebrand factor to the glycocalicin portion of platelet glycoprotein IB.

Authors:  R I Parker; H R Gralnick
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

8.  Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice.

Authors:  Kristof Vanschoonbeek; Kristiaan Wouters; Paola E J van der Meijden; Patrick J van Gorp; Marion A H Feijge; Marjolein Herfs; Leon J Schurgers; Marten H Hofker; Moniek P M de Maat; Johan W M Heemskerk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-08-28       Impact factor: 8.311

9.  Dual P2Y 12 receptor signaling in thrombin-stimulated platelets--involvement of phosphoinositide 3-kinase beta but not gamma isoform in Ca2+ mobilization and procoagulant activity.

Authors:  Paola E J van der Meijden; Simone M Schoenwaelder; Marion A H Feijge; Judith M E M Cosemans; Imke C A Munnix; Reinhard Wetzker; Regine Heller; Shaun P Jackson; Johan W M Heemskerk
Journal:  FEBS J       Date:  2007-12-13       Impact factor: 5.542

10.  Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.

Authors:  Felicitas Müller; Nicola J Mutch; Wolfdieter A Schenk; Stephanie A Smith; Lucie Esterl; Henri M Spronk; Stefan Schmidbauer; William A Gahl; James H Morrissey; Thomas Renné
Journal:  Cell       Date:  2009-12-11       Impact factor: 41.582

View more
  28 in total

1.  Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.

Authors:  Nadine J A Mattheij; Frauke Swieringa; Tom G Mastenbroek; Michelle A Berny-Lang; Frauke May; Constance C F M J Baaten; Paola E J van der Meijden; Yvonne M C Henskens; Erik A M Beckers; Dennis P L Suylen; Marc W Nolte; Tilman M Hackeng; Owen J T McCarty; Johan W M Heemskerk; Judith M E M Cosemans
Journal:  Haematologica       Date:  2015-12-31       Impact factor: 9.941

2.  The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies.

Authors:  Conglei Li; Siavash Piran; Pingguo Chen; Sean Lang; Alessandro Zarpellon; Joseph W Jin; Guangheng Zhu; Adili Reheman; Dianne E van der Wal; Elisa K Simpson; Ran Ni; Peter L Gross; Jerry Ware; Zaverio M Ruggeri; John Freedman; Heyu Ni
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

3.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

4.  Thrombin-dependent Incorporation of von Willebrand Factor into a Fibrin Network.

Authors:  Adam Miszta; Leonie Pelkmans; Theo Lindhout; Ganeshram Krishnamoorthy; Philip G de Groot; Coenraad H Hemker; Johan W M Heemskerk; Hilde Kelchtermans; Bas de Laat
Journal:  J Biol Chem       Date:  2014-11-07       Impact factor: 5.157

5.  Mitochondrially mediated integrin αIIbβ3 protein inactivation limits thrombus growth.

Authors:  Fang Liu; Graciela Gamez; David R Myers; Wayne Clemmons; Wilbur A Lam; Shawn M Jobe
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

Review 6.  Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.

Authors:  Reheman Adili; Megan Hawley; Michael Holinstat
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-25       Impact factor: 3.072

7.  Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury.

Authors:  Thomas V Colace; Jannielle Jobson; Scott L Diamond
Journal:  Bioconjug Chem       Date:  2011-09-08       Impact factor: 4.774

8.  Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.

Authors:  Claire S Whyte; Frauke Swieringa; Tom G Mastenbroek; Ausra S Lionikiene; Marcus D Lancé; Paola E J van der Meijden; Johan W M Heemskerk; Nicola J Mutch
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

9.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

10.  Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.

Authors:  Frauke Swieringa; Marijke J E Kuijpers; Moniek M E Lamers; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.